Showing results (201-210 of 285) with videos related to
Sort By:
Pageof 29
ERJ Open Research|March 15, 2021
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysisMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.Respiratory Research|February 2, 2023
X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association studyLystra P Hayden, Brian D Hobbs, Robert Busch, et al.Advances in Therapy|July 11, 2020
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyMaggie Tabberer, C Elaine Jones, Sally Kilbride, et al.The European Respiratory Journal|June 15, 2013
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortAlvar Agusti, Lisa D Edwards, Bartolomé Celli, et al.Science Advances|October 22, 2020
The structural basis for Z α1-antitrypsin polymerization in the liverSarah V Faull, Emma L K Elliston, Bibek Gooptu, et al.The Biochemical Journal|July 14, 2016
An antibody that prevents serpin polymerisation acts by inducing a novel allosteric behaviourNeda Motamedi-Shad, Alistair M Jagger, Maximilian Liedtke, et al.The International Journal of Biochemistry & Cell Biology|December 3, 2014
Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibodyLu Tan, Juan Perez, Marianna Mela, et al.COPD|May 17, 2014
Evaluating the role of inflammation in chronic airways disease: the ERICA studyDivya Mohan, Nichola S Gale, Carmel M McEniery, et al.Respiratory Research|June 7, 2020
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trialNicola C Day, Subramanya Kumar, Gerard Criner, et al.ERJ Open Research|September 3, 2021
Quantitative 18F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPDLaurence Vass, Marie Fisk, Joseph Cheriyan, et al.Pageof 29